ClinicalTrials.gov record
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
ClinicalTrials.gov ID: NCT01564784
Public ClinicalTrials.gov record NCT01564784. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AN OPEN-LABEL, RANDOMIZED PHASE 3 STUDY OF INOTUZUMAB OZOGAMICIN COMPARED TO A DEFINED INVESTIGATOR'S CHOICE IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY CD22-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Study identification
- NCT ID
- NCT01564784
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 326 participants
Conditions and interventions
Conditions
Interventions
- FLAG (fludarabine, cytarabine and G-CSF) Drug
- HIDAC (high dose cytarabine) Drug
- cytarabine and mitoxantrone Drug
- inotuzumab ozogamicin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2012
- Primary completion
- Mar 7, 2016
- Completion
- Jan 3, 2017
- Last update posted
- Jan 8, 2019
2012 – 2017
United States locations
- U.S. sites
- 96
- U.S. states
- 24
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Drug Services - UC San Diego Moores Cancer Center | La Jolla | California | 92037-0845 | — |
| UC San Diego Medical Center - La Jolla | La Jolla | California | 92037 | — |
| UC San Diego Moores Cancer Center | La Jolla | California | 92093-0698 | — |
| Children's Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles | Los Angeles | California | 90027 | — |
| Keck Hospital of USC | Los Angeles | California | 90033 | — |
| LAC+USC Medical Center | Los Angeles | California | 90033 | — |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| USC/Norris Comprehensive Cancer Center / Investigational Drug Services | Los Angeles | California | 90033 | — |
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| UCLA Drug Information/Investigation Drug | Los Angeles | California | 90095 | — |
| UCLA Hematology/Oncology Clinic | Los Angeles | California | 90095 | — |
| UCLA Ronald Reagan Medical Center | Los Angeles | California | 90095 | — |
| UCLA Rrmc | Los Angeles | California | 90095 | — |
| UC Irvine Medical Center | Orange | California | 92868-3201 | — |
| Children's Hospital of Orange County | Orange | California | 92868 | — |
| UC Irvine Medical Center | Orange | California | 92868 | — |
| Freidenrich Center for Translational Research (CTRU), Stanford University | Palo Alto | California | 94304 | — |
| UC San Diego Medical Center - Hillcrest | San Diego | California | 92103 | — |
| Martha Hamilton, Investigational Drug Services, Dept of Pharmacy | Stanford | California | 94305 | — |
| Stanford Cancer Institute | Stanford | California | 94305 | — |
| Stanford University Hospital and Clinics | Stanford | California | 94305 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| University of Colorado Hospital, Cancer Center Infusion Center | Aurora | Colorado | 80045 | — |
| University of Colorado Hospital | Aurora | Colorado | 80045 | — |
| Yale-New Haven Hospital & Smilow Cancer Center | New Haven | Connecticut | 06510 | — |
| Miami Children's Hospital | Miami | Florida | 33155 | — |
| MD Anderson Cancer Center Orlando - 5th Floor Investigational Pharmacy | Orlando | Florida | 32806 | — |
| MD Anderson Cancer Center Orlando | Orlando | Florida | 32806 | — |
| Orlando Heart Health Institute | Orlando | Florida | 32806 | — |
| Orlando Regional Medical Center | Orlando | Florida | 32806 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Investigational Drug Service, Emory University Clinic | Atlanta | Georgia | 30322 | — |
| The Emory Clinic | Atlanta | Georgia | 30322 | — |
| Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | — |
| Blood and Marrow Transplant Group of Georgia | Atlanta | Georgia | 30342 | — |
| Northside Hospital | Atlanta | Georgia | 30342 | — |
| Georgia Regents Medical Center Pharmacy, Georgia Regents University Cancer Center | Augusta | Georgia | 30912 | — |
| Georgia Regents University | Augusta | Georgia | 30912 | — |
| Northwestern Medical Faculty Foundation | Chicago | Illinois | 60611 | — |
| Northwestern Medicine Developmental Therapeutics Institute | Chicago | Illinois | 60611 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| University of Chicago Medical Center, Dept. of Pharmacy | Chicago | Illinois | 60637 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| University of Kansas Hospital | Kansas City | Kansas | 66160 | — |
| University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40202 | — |
| Norton Cancer Institute, Suburban | Louisville | Kentucky | 40207 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Oncology Investigational Drug Service | Baltimore | Maryland | 21231-2410 | — |
| The Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21231-2410 | — |
| Massachusetts General Hospital (MGH) | Boston | Massachusetts | 02114 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| University of Michigan Health System- | Ann Arbor | Michigan | 48109 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Karmanos Cancer Institute Weisberg Cancer Treatment Center | Farmington Hills | Michigan | 48334 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| University of New Mexico Comprehensive Cancer Center | Albuquerque | New Mexico | 87131-0001 | — |
| UNM Cancer Center | Albuquerque | New Mexico | 87131 | — |
| Monter Cancer Center | Lake Success | New York | 11042 | — |
| North Shore University Hospital | Manhasset | New York | 11030 | — |
| New York Presbyterian Hospital-Weill Cornell Medical College | New York | New York | 10021 | — |
| NewYork-Presbyterian Hospital | New York | New York | 10065 | — |
| Weill Cornell Medical College - New York-Presbyterian Hospital | New York | New York | 10065 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794-7007 | — |
| Stony Brook University Medical Center, The Cancer Center | Stony Brook | New York | 11794-9447 | — |
| Division of Hematology/Oncology, Stony Brook University Hospital | Stony Brook | New York | 11794 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794 | — |
| UNC Cancer Hospital Infusion Pharmacy | Chapel Hill | North Carolina | 27514 | — |
| UNC Hospitals - The University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599-7600 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | — |
| University Hospitals of Cleveland | Cleveland | Ohio | 44106 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| OU Medical Center Presbyterian Tower | Oklahoma City | Oklahoma | 73104 | — |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| IDS-investigational drug pharmacy Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Penn State Milton S. Hershey Medical Center, | Hershey | Pennsylvania | 17033 | — |
| Hollings Cancer Center | Charleston | South Carolina | 29425 | — |
| MUSC Hospital | Charleston | South Carolina | 29425 | — |
| Parkland Health and Hospital System | Dallas | Texas | 75235 | — |
| Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| University of Texas Southwestern Universtiy Hospital - William P Clements Jr. | Dallas | Texas | 75390 | — |
| UT Southwestern Medical Center at Dallas | Dallas | Texas | 75390 | — |
| UT Southwestern University Hospital- Zale Lipshy | Dallas | Texas | 75390 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| LDS Hospital | Salt Lake City | Utah | 84143 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
| University of Washington | Seattle | Washington | 98195 | — |
| West Virginia University Hospitals Pharmaceutical Services | Morgantown | West Virginia | 26506 | — |
| West Virginia University Hospitals | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01564784, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2019 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01564784 live on ClinicalTrials.gov.